Premium
Special management considerations for propranolol use in breastfed infants of mothers taking antihypertensives
Author(s) -
Aizman Leora,
Van Den Anker John,
Tender Jennifer,
Krishnan Anita,
Kirkorian Anna Yasmine
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14134
Subject(s) - propranolol , medicine , breastfeeding , pediatrics , infantile hemangioma , intensive care medicine , anesthesia
Propranolol is approved for treatment of infantile hemangiomas (IH). IH proliferation coincides with the time when most women are breastfeeding, yet there are no reports describing the clinical effects on infants treated with propranolol while being nursed by mothers on oral antihypertensive medications. We describe two cases of breastfed infants, with mothers taking multiple antihypertensives of different drug classes, who were initiated on propranolol for IH treatment and discuss the theoretical risk of propranolol use in this setting.